TREVOTAMIG
UNII NC5L6FUN6X

Substance Identification & Data

This profile provides standardized clinical and technical data for Trevotamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NC5L6FUN6X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2920215-79-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NC5L6FUN6X
CAS Registry Number
2920215-79-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TREVOTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13209
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trevotamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TREVOTAMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (298-GLUTAMINE), BISPECIFIC, ANTI-(HUMAN EPITHELIAL CELL ADHESION MOLECULE) (HUMAN-MUS MUSCULUS MONOCLONAL BA3182 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA3182 .KAPPA.-CHAIN FUSION PROTEIN WITH PEPTIDE LINKER (SRSGGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL BA3182 SINGLE-CHAIN VARIABLE REGION FRAGMENT VH-((GGS)4GG)-VL), DIMER
IMMUNOGLOBULIN H-GAMMA1_L-KAPPA-SCFVHL DIMER BISDISULFIDE, ANTI-(HOMO SAPIENS EPCAM (EPITHELIAL CELL ADHESION MOLECULE, TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1, TACSTD1, GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN 2, GA733-2, EPITHELIAL GLYCOPROTEIN 2, EGP-2, KSA, KS1/4 ANTIGEN, M4S1, TUMOR ANTIGEN 17-1A, EP-CAM, EPCAM, CD326)) AND SCFV ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY, BISPECIFIC, TETRAVALENT
TREVOTAMIG [INN]